LBA13 Phase III trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)
Oliver Sartor, D.E. Castellano Gauna, Ken Herrmann, Johann S. de Bono, Neal D. Shore, K.N. Chi, M. J. Crosby, J.M. Piulats Rodriguez, Aude Fléchon, X.X. Wei, Hakim Mahammedi, Guilhem Roubaud, H. ova, Samson Ghebremariam, Euloge Kpamegan, Teri Kreisl, Neda Delgoshaie, Katja Lehnhoff, Michael J. Morris, Karim Fizazi
Topics & Concepts
MedicineTaxaneClinical endpointInterim analysisProstate cancerInternal medicineEnzalutamideOncologyProgression-free survivalGastroenterologyCancerRandomized controlled trialUrologyChemotherapyBreast cancerAndrogen receptorProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsPeptidase Inhibition and Analysis